NEWRON PHARMACEUT. EO-20 Defensive Interval Ratio
NEWRON PHARMACEUT. EO-20 defensive interval ratio. NEWRON PHARMACEUT. EO-20 (NP5) has a Defensive Interval Ratio of 166 days as of December 2025. Defensive assets of €22.83 Million (cash €-, short-term investments €16.68 Million, receivables €6.16 Million) cover 166 days of daily cash needs of €137.25K/day. See NEWRON PHARMACEUT. EO-20 current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of NEWRON PHARMACEUT. EO-20 (2005–2025)
Defensive interval ratio of NEWRON PHARMACEUT. EO-20 from 2005 to 2025. This chart shows how NEWRON PHARMACEUT. EO-20's Defensive Interval Ratio has evolved across 17 annual periods from 2005 to 2025. As of December 2025, the ratio stands at 166 days, meaning defensive assets of €22.83 Million can fund 166 days of operations without new revenue. Check NEWRON PHARMACEUT. EO-20 liquidity resilience to evaluate the company's liquid asset resilience ratio.
NEWRON PHARMACEUT. EO-20 Defensive Interval Ratio by Year (2005–2025)
NEWRON PHARMACEUT. EO-20 defensive interval ratio by year from 2005 to 2025. The table below presents the year-by-year Defensive Interval Ratio for NEWRON PHARMACEUT. EO-20 from 2005 to 2025, covering 17 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see NEWRON PHARMACEUT. EO-20 assets under control.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 166 days | €22.83 Million | €137.25K/day | €- | €16.68 Million | ▼ -537 days |
| 2024 | 704 days | €45.32 Million | €64.40K/day | €- | €2.89 Million | ▲ +593 days |
| 2023 | 111 days | €8.79 Million | €79.25K/day | €- | €6.26 Million | ▼ -707 days |
| 2022 | 818 days | €11.29 Million | €13.81K/day | €- | €9.35 Million | ▼ -269 days |
| 2021 | 1087 days | €10.88 Million | €10.01K/day | €- | €9.57 Million | ▼ -219 days |
| 2020 | 1306 days | €24.66 Million | €18.88K/day | €- | €18.04 Million | ▲ +76 days |
| 2019 | 1230 days | €18.86 Million | €15.33K/day | €- | €17.11 Million | ▼ -209 days |
| 2018 | 1439 days | €17.47 Million | €12.14K/day | €- | €16.23 Million | ▼ -144 days |
| 2017 | 1583 days | €20.50 Million | €12.95K/day | €- | €19.44 Million | ▲ +1317 days |
| 2016 | 266 days | €4.85 Million | €18.21K/day | €- | €3.52 Million | ▼ -78 days |
| 2015 | 344 days | €6.14 Million | €17.84K/day | €- | €4.92 Million | ▼ -441 days |
| 2014 | 785 days | €9.66 Million | €12.30K/day | €- | €6.95 Million | ▲ +323 days |
| 2013 | 462 days | €7.68 Million | €16.63K/day | €- | €5.46 Million | ▲ +283 days |
| 2012 | 179 days | €5.68 Million | €31.74K/day | €- | €3.64 Million | ▼ -14 days |
| 2011 | 192 days | €1.49 Million | €7.75K/day | €- | €- | ▲ +125 days |
| 2009 | 68 days | €1.60 Million | €23.71K/day | €- | €1.60 Million | ▼ -97 days |
| 2005 | 164 days | €2.30 Million | €14.02K/day | €- | €- | — |